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The product of the bcl-2 proto-oncogene (TsujimotoSummary
et al., 1984; Bakhshi et al., 1985; Cleary et al., 1986)
is the most fully characterized member of a recentlyBcl-2 is a major regulator of programmed cell death,
identified family of proteins (Lin et al., 1993; Kozopas eta critical process in shaping the developing nervous
al., 1993; Boise et al., 1993; Oltvai et al., 1993; Yang etsystem. To assess whether Bcl-2 is involved in regulat-
al., 1995) that play a key role in regulating programmeding neuronal survival and in mediating the neuropro-
cell death. Bcl-2 protein is highly expressed in mosttective action of neurotrophic factors, we generated
neurons of the developing mouse nervous system (Abe-Bcl-2-deficient mice. At birth, the number of facial mo-
Dohmae et al., 1993; Merry et al., 1994). Expression oftoneurons, sensory, and sympathetic neurons was not
bcl-2 declines postnatally in many regions of the CNS,significantly changed, and axotomy-induced degener-
but remains at relatively high levels in the peripheralation of facial motoneurons could still be prevented
nervous system (Merry et al., 1994). After demonstratingby brain-derived neurotrophic factor (BDNF) or ciliary
that Bcl-2 prevents cell death in the immune systemneurotrophic factor (CNTF). Interestingly, substantial
(Hockenbery et al., 1990; Nun˜ez et al., 1990; Siegel etdegeneration of motoneurons, sensory, and sympa-
al., 1992), microinjection of bcl-2 cDNA was found tothetic neurons occurred after the physiological cell
prevent the degeneration of cultured neurons, whichdeath period. Accordingly, Bcl-2 is not a permissive
results from withdrawal of neurotrophins (Garcia et al.,
factor for the action of neurotrophic factors, and al-
1992; Mah et al., 1993; Allsopp et al., 1993). Moreover,
though it does not influence prenatal neuronal survival,
in transgenic mice, neuron-specific overexpression of
it is crucial for the maintenance of specific populations
Bcl-2 substantially protected neurons of the central andof neurons during the early postnatal period.
peripheral nervous system from both physiological and
axotomy-induced cell death (Dubois-Dauphin et al.,
1994; Martinou et al., 1994; Farlie et al., 1995). Therefore,
Introduction it was tempting to assume that Bcl-2 is the effector of
specific neurotrophic factors, particularly in view of the
Programmed cell death plays a fundamental role in the fact that in vitro, high levels of Bcl-2 protected neuro-
morphogenesis of multicellular organisms (Ellis et al., trophin-responsive neurons but not neurons responsive
1991; Raff, 1992). The nervous system is no exception, to ciliary neurotrophic factor (CNTF) (Garcia et al., 1992;
and a substantial proportion of the neurons initially Allsopp et al., 1993). However, the hypothesis that Bcl-2
formed die in later phases of neuronal development could be the mediator of the survival effect of neuro-
(Barde, 1989; Oppenheim, 1991; Johnson and Deck- trophins was challenged by the observation that no
werth, 1993). In the peripheral nervous system, pro- gross defects were apparent in the central and periph-
grammed cell death comes into play when outgrowing eral nervous system in bcl-2 knockout mice (Veis et
axons reach their target tissues and compete there for al., 1993; Nakayama et al., 1994), whereas neurotrophin
neurotrophic molecules, which are produced in limited knockout mice characteristically showed severe de-
quantities (Levi-Montalcini, 1987; Barde, 1989; Oppen- fects, predominantly in the peripheral nervous system
heim, 1991). Accordingly, the level of expression of these (Crowley et al., 1994; Jones et al., 1994; Ernfors et al.,
neurotrophic factors determines the extent of neuronal 1994; Conover et al., 1995; Farin˜as et al., 1994; Liu et
survival and the density of innervation of the target tis- al., 1995; for review, see Snider, 1994). Moreover, neuro-
sues. The concept of target-mediated trophic support trophins were recently found to influence neither bcl-2
of innervating neurons has been best established for mRNA levels nor those of other members of this gene
the members of the nerve growth factor (NGF) gene family, such as bcl-x and bax in cultured hippocampal
family that exert their effects on responsive neurons via and cerebellar granule neurons (Ohga et al., 1996). Fo-
members of the Trk family of protein tyrosine kinase cusing on the sympathetic nervous system, Greenlund
receptors assigned to individual neurotrophins, and via et al. performed in vitro analysis of primary neuronal
cultures from superior cervical ganglia (SCG) of bcl-2the low-affinity neurotrophin p75 receptor that appears
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knockout mice to investigate whether Bcl-2 plays a role 1993; Young and Korsmeyer, 1993), the integrity of this
region was preserved in the targeted allele. The strategyduring the period of naturally occurring cell death
(NOCD) or in the development of trophic factor indepen- for disrupting the bcl-2 gene is detailed in Experimental
Procedures and in Figure 1. We used two independentlydence in mature sympathetic neurons. Freshly dissoci-
ated sympathetic neurons from Bcl-2-deficient animals targeted embryonic stem (ES) cell clones to generate
homozygous bcl-22/2 mice that exhibited the same phe-died morerapidly than wild- type cultureswhen deprived
of NGF, whereas in cultures previously maintained in the notype. Western blot analysis, using equal amounts of
hippocampal protein extracts from all genotypes with apresence of NGF for 3 weeks, there was no difference
between the effect of NGF deprivation in wild- type and peptide antibody against Bcl-2, confirmed the absence
of bcl-2 expression in the bcl-22/2 mice, and demon-homozygous or heterozygous bcl-2 mutant mice. From
these in vitro observations, it was concluded that Bcl-2 strated a gene-dosage effect of reduced protein levels
in heterozygous animals (Figure 1C). The phenotype ofis an important regulator of the survival of sympathetic
neurons after NGF deprivation during the period of the bcl-22/2 mice was essentially the same as described
previously by Veis et al. (1993) and Nakayama et al.NOCD, but it is not involved in the development of tro-
phic factor independence in mature sympathetic neu- (1994), with a similar effect upon body mass but with a
slightly prolonged lifespan (see Experimental Proce-rons. Nevertheless, it remains to be established whether
these in vitro observations reflect the role played by dures). The only notable difference was a less severe
polycystic malformation of the kidneys of our bcl-22/2Bcl-2 in vivo in regulating the survival of not only sympa-
thetic but also other types of neurons of the developing animals. Analysis of clinical parameters of kidney func-
tion showed no difference in the relative levels of theand mature central and peripheral nervous system, or
whether Bcl-2 is a permissive factor for the protective electrolytes potassium, sodium, calcium, phosphorus,
and magnesium in 10 week-old bcl-22/2 mice (n 5 4)action of specificneurotrophic factors under pathophys-
iological conditions, as after axotomy of motoneurons compared with wild-type littermates (n 5 16). Serum
creatinine and blood urea nitrogen levels were lowerin newborn mice.
To approach these unresolved issues, we produced than those reported by Veis et al. (1993), exhibiting only
a small (1.7-fold) increase in serum creatinine levelstransgenic mice carrying a disrupted bcl-2 locus by re-
placement with the Escherichia coli lacZ reporter gene. (mean 6 SEM: 0.38 6 0.11 mg/dl, n 5 4, versus 0.22 6
0.03 mg/dl, n 5 14 in wild-type mice, p > 0.05) and aWe examined the well- characterized protective effects
of brain-derived neurotrophic factor (BDNF) and CNTF moderate (2-fold) increase in blood urea nitrogen levels
(mean 6 SEM: 74 6 11 mg/dl, n 5 4, versus 38 6 3 mg/(Sendtner et al., 1990, 1992a; Yan et al., 1992; Koliatsos
et al., 1993) on axotomy-induced motoneuron cell de- dl, n 5 16 in wild-type mice, p < 0.05). Examination of
younger animals (P13) revealed no statistically signifi-generation in homozygous mutant (bcl-22/2) and wild-
type mice. This approach seemed to be of particular cant difference (p > 0.05) between mutant and wild-type
mice, both in the serum creatinine (mean 6 SEM: 0.35interest, since Bcl-2 is highly expressed in motoneurons
during the embryonic and early postnatal period (Merry 6 0.05 mg/dl, n 5 3, versus 0.30 6 0.08 mg/dl, n 5 5
in wild-type mice) and blood urea nitrogen levels (meanet al., 1994). Our findings demonstrate that Bcl-2 is not
required for mediating the survival-promoting effects of 6 SEM: 46 6 5 mg/dl, n 5 3, versus 38 6 4 mg/dl, n55
in wild-type mice).BDNF and CNTF on axotomized motoneurons in new-
born bcl-22/2 mice. Nevertheless, this molecule essen-
tiallycontributes to thesurvival of motoneurons, sensory BDNF and CNTF Prevent the Degeneration
of Motoneurons in Newborn bcl-22/2 Miceand sympathetic neurons in the postnatal period, subse-
quent to the period in which NOCD takes place. The after Axotomy
Neuron-specific overexpression of Bcl-2 in transgenicloss of a substantial number of neurons in the bcl-22/2
mice indicates that other members of the bcl-2 gene mice protects motoneurons from degeneration after ax-
otomy in newborn animals (Dubois-Dauphin et al., 1994;family do not seem to compensate fully for the absence
of Bcl-2 in the nervous system. Farlie et al., 1995). It is also well established that neuro-
trophic molecules like BDNF and CNTF protect moto-
neurons from axotomy-induced degeneration in the
Results early postnatal period (Sendtner et al., 1990, 1992a; Yan
et al., 1992; Koliatsos et al., 1993). In view of the fact
Targeting the bcl-2 Gene and Generation that the presence of Bcl-2 is necessary for the survival
of bcl-22/2 Mutant Mice response of chick neurons to BDNF but not to CNTF
The mouse bcl-2 gene consists of three exons that en- (Allsopp et al., 1993, 1995), we approached the question
code for two different proteins, Bcl-2a and Bcl-2b, which as to whether Bcl-2 has a permissive function for the
arise through different RNA termination reactions (Neg- protective action of BDNF, but not for CNTF, upon moto-
rini et al., 1987). To generate mice lacking both isoforms, neurons after axotomy in the early postnatal phase. The
we targeted the second exon that contains most of the facial nerve of 2 day-old mice was unilaterally tran-
protein-coding sequence.We provided a genetic marker sected, and BDNF or cytochrome C was applied in
of the mutation by placing the bacterial LacZ gene under pieces of gel foam soaked in PBS buffer containing 5
the transcriptional regulatory sequences of the bcl-2 mg of each protein. At postnatal day 9 (P9), both wild-
gene. Since the 59 untranslated sequence may have an type and bcl-22/2 mice showed typical signs of facial
important role in regulating bcl-2 expression (Negrini et nerve transection, including loss of movement of whis-
ker hair and paralysis of the facial musculature thatal., 1987; Kondo et al., 1992; Chleq-Deschamps et al.,
Targeted Disruption of bcl-2 Gene and Neuronal Cell Death
77
Figure 1. Targeted Disruption of the Mouse bcl-2 Gene
(A) Schematic diagram of the strategy used to target the bcl-2 locus. The structure of the endogenous murine bcl-2 gene is shown on the
center panel, and that of the targeting construct is shown above. Thin horizontal lines represent mouse genomic DNA; thick lines represent
genomic sequences incorporated into the targeting vector. Exons are indicated by either shaded (untranslated regions) or black boxes (protein
coding sequences). The approximate size of the second intron is also shown (z15 kb). The RSV-neo selection cassette and the coding region
of the bacterial lacZ gene are shown as open boxes, with arrows indicating the orientation of transcription. The PGK-tk cassette is illustrated
by a wavy line. The translation initiation and the stop codons of the two Bcl-2 protein forms are indicated. Homologous recombination
generates a fusion of the 59 untranslated region of the bcl-2 with the lacZ gene. The targeted allele is illustrated at the bottom. The 860 bp
EcoRI-SpeI fragment used to identify the diagnostic 6.3 kb EcoRI-KpnI and 9.3 kb EcoRI fragments (bottom arrows) is indicated (probe A).
Abbreviations: F, Fsp; K, KpnI; (K), KpnI blunt; R, EcoRI; S, SpeI; pA, polyadenylation site. (B) Southern blot analysis of tail DNA derived from
the progeny of heterozygous mutant mice. The DNA was digested with EcoRI and KpnI and hybridized with the external probe, shown in
diagram A. The genotypes of the biopsied mice are indicated. The wild-type bcl-2 allele generates a 6.3 kb EcoRI-KpnI fragment, whereas in
the disrupted allele, the destruction of the endogenous KpnI site and the presence of an EcoRI site in the targeting vector yield the diagnostic
9.3 kb EcoRI fragment.
(C) Western blot analysis of hippocampal lysates from mice genotyped as wild-type, heterozygous and homozygous for the disrupted bcl-2
allele. The protein blot was incubated with polyclonal antiserum specific to mouse Bcl-2. Bcl-2 immunoreactivity is absent in extracts from
bcl-22/2 mice, whereas a distinct band of the expected size (25 kD) is detectable in hippocampal lysates from wild-type and heterozygous
mice.
accompany the rapid degeneration of facial motoneu- In view of the findings reported in neurons of the chick
peripheral nervous system by Davies and coworkersrons following early postnatal axotomy (Kreutzberg,
1986; Sendtner et al., 1990). As expected (Sendtner et (Allsopp et al., 1993; 1995), it is particularly interesting
that not only CNTF, but also BDNF, is capable of pre-al., 1990, 1992a; Dubois-Dauphin et al., 1994), more than
90% of the cell bodies ipsilateral to the transected facial venting the death of axotomized mouse motoneurons
in the absence of Bcl-2.nerve were lost in the cytochrome C-treated wild-type
(Figure 2A) and bcl-22/2 mice (Figure 2B; Table 1). The
few remaining motor neurons showed severe signs of Progressive Degeneration of Facial Motoneurons
in the Course of Early Postnatal Developmentatrophy, exhibiting displaced nuclei and pronounced
chromatolysis. Application of BDNF to the proximal To our surprise, in early postnatal (P9) bcl-22/2 animals
used in the experiments described above, motoneuronsstump of the lesioned nerve increased the survival of
motoneurons both in wild-type and bcl-22/2 mice (Table situated predominantly in the lateral part of the facial
nucleus appeared shrunken, suggestive of an ongoing1). One week after lesion, 54% and 40% of motoneurons
survived in wild-type and bcl-22/2 mice, respectively. degenerative process (Figure 2D). Indeed, the number
of facial motoneurons on the unlesioned side of P9 bcl-There was no statistically significant difference between
the effect of BDNF in wild-type and bcl-22/2 animals. In 22/2 mice amounted only to 71% of the number present
in wild-type animals (p<0.05) (Table 2). At P28 and P44,addition to a protective effect of BDNF upon neuronal
number, surviving facial motoneurons also showed the number of motoneurons in the facial nuclei of bcl-
22/2 animals was 68% and 67%, respectively, of themarkedly less evidence of atrophic changes in BDNF-
treated wild-type and bcl-22/2 animals (data not shown). neurons present in age-matched controls (p<0.05,
p<0.001) (Table 2), indicating that the process of moto-Thus, in the absence of Bcl-2, local application of recom-
binant BDNF prevented the lesion-induced death of fa- neuron degeneration was already over at the age of P9.
In the mouse facial nucleus, NOCD takes place pre-cial motoneurons, demonstrating that Bcl-2 is not a per-
missive factor for the action of BDNF on neuronal dominantly during the last 4 days of embryonic develop-
ment, with a residual amount of neuronal death stillsurvival in this system. We have also investigated the
effect of CNTF on the survival of lesioned facial moto- occuring over the next 3 days following birth (Ashwell
and Watson, 1983). Therefore, it was interesting to knowneurons in the same lesion model, in bcl-22/2 mice. As
for BDNF, application of CNTF (2.5 mg) prevented the whether the neuronal cell loss in bcl-22/2 mice occured
during, or even before, the main period of physiologicalloss of axotomized motoneurons to a similar extent in
both wild-type and homozygous mutant mice (Table 1). cell death. For this purpose, we compared the number
Neuron
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Figure 2. Appearance of Motoneurons in the Facial Nucleus of the bcl-2-/- Mice
Nissl-stained paraffin embedded sections of the brain stem of 9 day-old wild-type (A and C) and bcl-22/2 (B and D) mice 7 days after a
unilateral transection of the facial nerve. As expected, a significant retrograde degeneration was detectable ipsilateral to the lesion (Les). The
margin of the unlesioned facial nucleus, contralateral to the lesioned side is indicated by broken lines. A higher magnification of the unlesioned
sides of both wild-type (C) and bcl-22/2 (D) mice is shown at the bottom. In contrast to the wild type (C), numerous motoneurons in the bcl-
22/2 animals (D), located mainly at the lateral part of the facial nucleus (white arrows), appear shrunken and chromatolytic. Scale bars represent
510 mm (A and B) and 250 mm (C and D).
of motoneurons present in intact facial nuclei of bcl-22/2 precede the physiological cell death period, or it was not
due to a reduced formation of motoneurons. Moreover,and wild-type mice at an early (embryonic day 16.5) and
a late (postnatal day 3) stage of the cell death period. physiological cell death was not enhanced beyond its
normal level, since no significant loss of neurons wasA small but not statistically significant difference was
observed between the number of facial motoneurons detected at P3.
The above findings demonstrate that the absence ofpresent in each genotype at both E16.5 and P3 (Table
2). In bcl-22/2 mice, 94% of the number of facial moto- the Bcl-2 does not significantly influence the develop-
ment of motoneurons before or during the main periodneurons counted in wild-type animals were present at
E16.5 and 85% at P3. The fact that at E16.5 there was of physiological cell death. Rather, Bcl-2 exerts its influ-
ence beyond this period, subsequent to the phase whereno difference in neuronal number indicated that the in-
creased motoneuron cell death in bcl-22/2 mice did not the majority of neuronal loss normally takes place.
Table 1. Effect of BDNF and CNTF Treatment on the Number of Facial Motoneurons in Newborn bcl-22/2 Mice
Number of Surviving Neurons 6 SEM
Treatment Control side Lesioned Side Percent
Cyt. C Wild-Type 3220 255 8 (n 5 1)
bcl-22/2 2029 6 148 129 6 20 6 6 1 (n 5 4)
BDNF Wild-Type 3152 6 161 1704 6 139 54 6 4 (n 5 7)
bcl-22/2 2294 6 195 865 6 111 40 6 7† (n 5 7)
CNTF Wild-Type 2715 6 84 1172 6 131 43 6 4 (n 5 5)
bcl-22/2 2270 6 113 1157 6 370 50 6 15† (n 5 3)
A unilateral transection of the facial nerve on the right side was made in 2 day-old wild-type and bcl-22/2 animals, and BDNF, CNTF, or
cytochrome C was applied as described previously (Sendtner etal., 1992a, 1992b).Seven days later, the animals were perfused and motoneurons
with apparent nucleoli were counted on serial 7 mm paraffin embedded sections of the brainstem stained with cresyl violet. Values shown
are the mean 6 SEM of motoneurons counted in the lesioned side compared to the mean 6 SEM of motoneurons present in the facial nucleus
of the unlesioned contralateral side. The percentage (%) of the survival of motoneurons in the lesioned compared to the unlesioned side 6
SEM is also shown. The statistical significance of the difference between the motoneurons rescued by BDNF or CNTF in bcl-22/2 versus wild-
type animals was assessed by Student’s t-test.
† p . 0.05, not significant
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Bcl-2 Is Highly Expressed in Neonatal FacialTable 2. Number of Facial Motoneurons in Wild-Type and bcl-
22/2 Mice Motoneurons and Is Retained in Adulthood
The location of degenerating motoneurons in the lateralPercent of
part of the facial nucleus prompted us to examine moreAge Wild-Type Mice bcl-22/2 Mice Wild-Type
closely the pattern of Bcl-2 expression within the facial
E16.5 6791 6 81 (n 5 2) 6392 6 15 (n 5 12) 94
nucleus. Using a peptide antibody against Bcl-2 in brain3 Days 3187 6 209 (n 5 7) 2717 6 228 (n 5 5) 85
sections containing the facial nuclei from mice at the9 Days 3121 6 128 (n 5 11) 2218 6 117 (n 5 13) 71*
age of P50, we observed distinct staining with a charac-28 Days 3310 6 433 (n 5 3) 2262 6 220 (n 5 6) 68*
44 Days 3246 6 255 (n 5 9) 2169 6 51 (n 5 7) 67* teristic punctate appearance throughout the cytoplasm
(Hockenbery et al., 1991; Merry et al., 1994) in motoneu-Paraffin serial sections (7 mm) of the brain stems from age-matched
rons of wild-type animals (Figures 3A, 3C, and 3E), butunlesioned bcl-22/2 and wild-type animals were Nissl-stained, and
nucleoli or facial motoneurons were counted in every fifth section. not in homozygous mutants (Figures 3B and 3D). Inter-
Values (not corrected for split nucleoli) shown are mean 6 SEM estingly, motoneurons in the lateral part of the facial
of each group. Statistical significance of the difference between nucleus expressed particularly high levels of Bcl-2 (Fig-
motoneuron number in bcl-22/2 versus wild-type mice was deter- ure 3A), exactly in the part of the nucleus where the
mined by Student’s t-test. *p , 0.05 **p , 0.001
highest number of degenerating motoneurons was ob-
served at P9 (Figure 2D). Replacement of the bcl-2 gene
by lacZ allowed us to perform histochemical analysis ofEffect of Axotomy on the Survival of Facial
the facialnuclei of young mice. At postnatalday 9, strongMotoneurons in P28 bcl-22/2 Animals
b-galactosidase activity was observed in a population
It is well established that the high vulnerability of moto-
of neurons residing in the most lateral butalso the medial
neurons to axotomy in the early postnatal period gradu-
margins of the facial nucleus in heterozygous animals
ally decreases, and by 4 weeks after birth, only 20% of
(Figure 4).
neurons die after axotomy, as compared with over 90%
at the time of birth (Schmalbruch, 1984; Pollin et al.,
1991; Snider et al., 1992). Whilst Bcl-2 appears to be Loss of Sensory and Sympathetic Neurons
during the Early Postnatal Periodnecessary for early postnatal maintenance of a substan-
tial proportion of motoneurons, we examined whether Bcl-2 protein is widely expressed both in the developing
and the adult peripheral nervous system (Merry et al.,Bcl-2 influences the extent of survival of axotomized
motoneurons in 28 day-old animals, a timepoint when 1994). Moreover, overexpression of Bcl-2 in sympathetic
and sensory neurons prevents cell death induced bymost of the lesioned motoneurons survive in the ab-
sence of added neurotrophic factors. Degeneration of withdrawal of the corresponding neurotrophins (Garcia
et al., 1992; Allsopp et al., 1993). Recently, it was alsoaxotomized facial motoneurons in 4 week-old mice is
detectable 1 week postaxotomy, and most of the neu- shown that sensory neurons isolated from dorsal root
ganglia of newborn mice overexpressing Bcl-2 survivedronal loss hasoccured by 2 weeks postlesion, with some
additional loss of neurons taking place in the following significantly longer when cultured in the absence of NGF
than neurons from wild-type mice (Farlie et al., 1995).week (Kou et al., 1995). Similar findings have also been
reported for spinal motoneurons after limb amputation Therefore, we investigated whether, in analogy to our
findings in motoneurons, bcl-2 elimination also resulted(Crews and Wigston, 1990). Therefore, we considered
2 weeks postaxotomy as an appropriate timepoint for in increased degeneration of sensory and sympathetic
neurons.examining whether motoneurons in bcl-22/2 mice are
less resistant to axotomy compared to wild-type mice, We analyzed the third lumbar (L3) DRGs from P3, P9,
and P44 mice (Table 4). The number of neurons in bcl-also taking into account that bcl-22/2 mice have a limited
lifespan and there is an increased frequency of mortality 22/2 mice at P3 was not significantly reduced (95% of
the number present in wild-type mice). However, thereafter the analyzed age (P44). For this purpose, the facial
nerve was unilaterally transected in 28 day-old animals, was a progressive decrease in the neurons present in
the DRG of bcl-22/2 animals, amounting to 90% of theand 16 days later, the number of facial motoneurons
was determined. The lesion at this age resulted in the wild type at P9 (p<0.005) and 56% at P44 (p<0.001)
(Table 4). Whilst the remaining sensory neurons in thesame proportion of motoneuron degeneration in both
mutant and wild-type animals (Table 3). Thus, the ab- ganglia of mutant mice appeared morphologically nor-
mal, we determined the soma size of 1000 neurons (L3,sence of Bcl-2 does not render motoneurons more vul-
nerable to injury at this age. DRG) from bcl-22/2 and wild-type mice at P44 to examine
Table 3. Effect of Axotomy on the Survival of Facial Motoneurons in 28 day-old bcl-22/2 Mice
Contralateral to Lesion Ipsilateral to Lesion Percent Survival
Wild-Type Mice 3696 6 149 (n 5 6) 2908 6 135 (n 5 6) 79*
bcl-22/2 Mice 2189 6 55 (n 5 6) 1712 6 113 (n 5 6) 78*
A unilateral transection of the facial nerve was made in 28 day old- bcl-22/2 and wild-type mice, and 16 days later the animals were perfused
and facial motoneurons were counted as in Table 1. Values (not corrected for split nucleoli) shown, are mean 6 SEM of each group. The
significance levels were determined by Student’s t-test.
* p , 0.005.
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Figure 3. Immunohistological Detection of Bcl-2 in the Lateral Part of the Facial Nucleus of Mice at the Age of P50
Coronal sections through the brainstem of P50 wild-type (A, C, and E) and bcl-22/2 (B and D) animals immunohistochemically stained with an
antibody against mouse Bcl-2. Bcl-2 immunoreactive motoneurons are present throughout the facial nucleus of wild-type animals (A, C, and
E). A higher magnification of an area that shows more intense Bcl-2 immunoreactivity in the lateral part of the nucleus (arrow in C), reveals
the characteristic punctate appearance of the immunoreactivity throughout the cytoplasm (E). No staining was observed in the bcl-22/2 mice
(B and D).
Scale bars represent 260 mm (A and B) and 130 mm (C and D).
whethera specificpopulation of sensory neurons is pref- present in wild-type mice). However, a substantial de-
crease of sympathetic neurons was detected in the SCGerentially lost. The histogram in Figure 5 indicates that
although both small and large subpopulations of DRG of bcl-22/2 animals at P10, amounting to 60% of the wild
type (p<0.005) and 58% at P44 (p<0.05) (Table 5). Theneurons were reduced in bcl-22/2 animals, the subpopu-
lation of large sensory neurons was more severely af- remaining sympathetic neurons in the SCG of bcl-22/2
animals showed no evidence of degenerative changes.fected. Neurons smaller than 500 mm2 were reduced
by 34%, whereas larger neurons were reduced by
73%. Sections of DRGs from adult bcl-21/2 animals Discussion
(1–2 months old, n 5 3) were histochemically stained
with X-Gal and subsequently immunohistochemically The presence of the Bcl-2 protein in the mammalian
nervous system during the period of NOCD and its main-stained for Neurofilament-Heavy chain (NF-H), which
identifies predominantly large DRG neurons, and for BSI tenance beyond this period (Abe-Dohmae et al., 1993;
Merry et al., 1994) is consistent with an essential rolelectin and Substance P (SP), which stain distinct popula-
tions of small DRG neurons (Lawson, 1992; Silos-Santi- played by Bcl-2 in the control of neuronal survival. To
investigate this role, we generated mice carrying a nullago et al., 1995). Intense b-galactosidase activity was
revealed inmany NF-H-positive neurons (Figures 6A and mutation of the Bcl-2 gene by simultaneous replacement
with the lacZ gene. We focused our attention upon three6B) but not in the SP- or BSI lectin-positive neurons
(Figures 6C and 6D). This observation is consistent with well-defined and representative regions of the central
and peripheral nervous systems, the motoneurons ofthe more pronounced reduction of the number of large
sensory neurons, as demonstrated by the size distribu- the facial nucleus, the sensory neurons of thedorsal root
ganglia, and the sympathetic neurons of the superiortion histogram. Taken together with the results on facial
motoneurons, the above findings indicate that neurons cervical ganglion. We have determined the number of
these neurons at distinct developmental stages toevalu-normally expressing higher levels of Bcl-2 protein tend
to be preferentially eliminated in the bcl-22/2 mice. ate potential neuronal deficits due to the absence of
Bcl-2. We have also investigated axotomy-induced de-We next examined sympathetic neurons of SCG to
determine whether Bcl-2 is also critical for the postnatal generation of motoneurons at different developmental
periods, as well as the ability of neurotrophic factors,maintenance of this population of neurons. As shown
in Table 5, the number of SCG neurons was not signifi- namely BDNF and CNTF, to suppress neuronal cell
death in the absence of Bcl-2, using a well- establishedcantly reduced in bcl-22/2 mice at P3 (87% of the number
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Table 4. Number of Dorsal Root Ganglion Neurons in Wild-Type
and bcl-22/2 Mice
Percent of
Age Wild-Type bcl-22/2 Wild-Type
3 Days 6020 6 410 (n 5 9) 5690 6 540 (n 5 4) 95
9 Days 6480 6 90 (n 5 3) 5850 6 60 (n 5 3) 90*
44 Days 6190 6 294 (n 5 4) 3450 6 270 (n 5 4) 56**
Paraffin 7 mm serial sections of L3 dorsal root ganglia from P3, P9,
and P44 mice were stained with cresyl violet, and neurons with a
clear nucleolus were counted in every tenth section. Values (not
corrected for split nucleoli) shown are mean 6 SEM of each group.
Significance levels were determined by Student’s t-test.
* p , 0.005, ** p , 0.001.
NOCD, since numerous motoneurons are lost in bcl-22/2
mice until P9. Other members of the Bcl-2 family, like
bcl-x (Boise et al., 1993) or other as yet unidentified
apoptotic/anti-apoptotic molecules, may be the major
effectors during the formation of neuronal progenitors,
and during the period of NOCD. Indeed Bcl-x-deficient
mice die around embryonic day 13, displaying extensive
apoptotic cell death in postmitotic immature neurons of
the developing brain, spinal cord, and dorsal root gan-
glia (Motoyama et al., 1995). The presence of Bcl-2-
dependent and -independent cell death mechanisms
operating at distinct periods during neuronal develop-Figure 4. Bcl-2 Expression Detected as b-gal Activity in the Facial
ment has also been deduced from the observations ofNucleus of bcl-21/2 Mice
Martinou et al. (1994), who produced transgenic miceCoronal sections through the brainstem of 9 day-old bcl-21/2 animals
overexpressing Bcl-2 either during or after NOCD. Fromwere histochemically stained with X-Gal to reveal the distribution
of b-galactosidase activity. Counterstained sections reveal b-gal the rescue of neurons during NOCD, it was concluded
activity (blue granules) in motoneurons situated in the medial (A) or that Bcl-2 is essentially involved in this process (Mar-
lateral (B) parts of the facial nucleus. No b-gal activity was observed tinou et al., 1994). Our gene-targeting experiments do
in wild-type littermates (C). Scale bars represent 100 mm (A) and 25 not support this conclusion, since the consequences of
mm (B and C).
bcl-2 inactivation became apparent after, and not dur-
ing, NOCD. This indicates that the presence of Bcl-2 is
necessary to maintain survival of motoneurons in theexperimental model of facial nerve lesion in newborn
mice. early postnatal period. The protective effect of high lev-
els of Bcl-2 during NOCD (Martinou et al., 1994) may
reflect the interchangeability of different survival mecha-Bcl-2 Is Required for the Postnatal
Maintenance of Facial Motoneurons nisms that operate during this period. The conclusions
drawn from Bcl-2 overexpression experiments with re-Our investigations demonstrated a progressive degen-
eration of motoneurons during the early postnatal period spect to the physiological importance of Bcl-2 are remi-
niscent of the observations made with various membersin bcl-22/2 animals. No significant neuronal loss was
observed between embryonic day 16.5 and postnatal of the NGF family. BDNF, NT-3, and NT-4/5 support the
survival of embryonic motoneurons in culture (Oppen-day 3, a timeperiod during which most of NOCD takes
place in mice (Ashwell and Watson, 1983). This indicates heim et al., 1992; Henderson et al., 1993; Hughes et al.,
1993), they interfere with NOCD in vivo (Oppenheim etthat in the mouse facial nucleus, Bcl-2 is not required
for the formation of neuronal progenitor cells or the al., 1988, 1992), and they also protect motoneurons from
axotomy-induced degeneration (Sendtner et al., 1992;regulation of neuronal survival during the period of
NOCD. Rather, the presence of Bcl-2 is important in the Yan et al., 1992; Hughes et al., 1993; Koliatsos et al.,
1993, 1994). However, no motoneuron defects becamepostnatal period, subsequent to NOCD. Accordingly,
distinct mechanisms seem to regulate facial motoneu- apparent after inactivation of the individual genes of
these neurotrophins (Ernfors et al., 1994; Farin˜as et al.,ronsurvival duringdifferent developmental periods. Sur-
vival during the early and most dramatic phase of NOCD 1994; Jones et al., 1994) or the combination of BDNF
and NT4/5 (Conover et al., 1995; Liu et al., 1995). Thisis characterized by the absence of an absolute require-
ment for Bcl-2. Either Bcl-2 is one of several players indicates that in motoneurons, as in many other neurons
of the central nervous system, a great variety of mecha-with broadly overlapping function, or its absence is com-
pensated for by appropriately modified expression of nisms are involved in the regulation of NOCD. Accord-
ingly, the results of Bcl-2 overexpression experimentsrelated apoptotic/antiapoptotic molecules, since no sig-
nificant loss of neurons became apparent before P3. reflect the interchangeability of these different mecha-
nisms. However, they permit only limited conclusionsHowever, different mechanism(s) that require the pres-
ence of Bcl-2 seem to come into play subsequent to to bedrawn about the relative importanceof the different
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Figure 5. Size Distribution Analysis of DRG
Sensory Neurons in bcl-22/2 and Wild-Type
Mice at the Age of P44
Cell size histograms from lumbar DRG of
wild-type or bcl-22/2 mice. The number of
cells falling into each size category is ex-
pressed as a percentage of total cells present
in the wild-type ganglia. p < 0.001 comparing
the two distributions using the x2 test.
mechanisms under physiological conditions. Although Degeneration of Motoneurons Occurs
Predominantly in the Lateral Part of thegene-targeting experiments generally provide more rel-
evant information on these aspects, they nevertheless Facial Nucleus
Immunocytochemical and histochemical analyses dem-have to be interpreted cautiously. The function of one
missing gene for instance, can be compensated for by onstrated the presence of Bcl-2 protein in facial moto-
neurons of both newborn and adult mice. We found thatthe overexpression of a related gene, as has been dem-
onstrated for the compensatory increase of myf-5 in the expression pattern of Bcl-2 in the facial nucleus is
more widespread during the early postnatal period andMyoD knockout mice (Rudnicki et al., 1992).
becomes more restricted later in development. Interest-
ingly, degenerating motoneurons were predominantly
situated in the lateral part of the facial nucleus in bcl-
22/2 mice, corresponding to the distribution of neurons
showing the highest levels of Bcl-2 expression in adult
wild-type animals, and implying the importance of Bcl-2
for the maintenance of these neurons in the postnatal
period. It is possible that the medially located motoneu-
rons that express Bcl-2 at early developmental stages
do not degenerate in the absence of Bcl-2, since they
are protected by other survival mechanisms. In contrast,
most laterally located motoneurons seem to be largely
dependent onBcl-2, continue toexpress it later in devel-
opment, as shown by immunohistochemistry at P50
(Figure 3), and are not able to overcome the absence of
this molecule. Additional immunohistochemical analysis
with a b-gal antibody in animals at P60 revealed the
presence of numerous b-gal-positive motoneurons in
the facial nucleus of heterozygous mice but only a few
neurons in homozygous mutant mice, indicating that
neurons that would normally express Bcl-2 have been
eliminated from the bcl-22/2 mice (data not shown).
Mouse facial musculature is represented within the
Table 5. Number of Superior Cervical Ganglion Neurons in Wild-
Type and bcl-22/2 Mice
Percent of
Age Wild-Type bcl-22/2 Wild-TypeFigure 6. bcl-2 Expression Detected as b-gal Activity in the DRG
of bcl-21/2 Mice 3 Days 14980 6 1780 (n 5 4) 13060 6 110 (n 5 2) 87
10 Days 12060 6 1310 (n 5 7) 7210 6 290 (n 5 8) 60*Coronal sections through a DRG of a 1 month-old bcl-21/2 animal
44 Days 9140 6 1780 (n 5 3) 5330 6 450 (n 5 6) 58**were histochemically stained for LacZ. Subsequent immunofluores-
cence detection of Neurofilament-H (NF-H) or Substance P (SP) or Paraffin 7 mm serial sections of superior cervical ganglia from P3,
of BSI lectin revealed that all (100%) of X-gal stained neurons were P10, and P44 mice were stained with cresyl violet, and neurons with
also immunoreactive for NFH (A and B), whereas X-gal staining was a clear nucleolus were counted in every tenth section. Values (not
never detectable (0% of X-gal-stained neurons) in SP- or BSI lectin- corrected for split nucleoli) shown are mean 6 SEM of each group.
positive stained neurons (C and D, respectively). White arrow indi- Significance levels were determined by Student’s t-test.
cates an example of a NFH-positive neuron that expresses b-gal. * p , 0.005, ** p , 0.05.
Scale bars represent 50 mm (A) and 20 mm (B–D).
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facial nucleus such that neurons supplying the nasola- et al., 1994; Dubois-Dauphin et al., 1994). In newborn
mice, axotomized motoneurons die by an apoptotic pro-bial musculature are located in the lateral portion of the
cess within 5 days, with a peak that is observed verynucleus, while the auricular musculature is innervated
rapidly, 28 h after the lesion (De Bilbao and Dubois-by motoneurons in the medial part (Ashwell, 1982). Thus,
Dauphin, 1996). This extreme vulnerability decreasesthe immature facial features, like the more rounded nose
during the following 4 weeks, by which age approxi-observed by us and others in bcl-22/2 mice after the first
mately 80% of neurons survive after axotomy (Schmal-postnatal week (Veis et al., 1993; Nakayama et al., 1994),
bruch, 1984; Pollin et al., 1991; Snider et al., 1992). Themay result from atrophy of the musculature that receives
ability of increased expression of Bcl-2 protein to pro-reduced innervation after degeneration of motoneurons
tect neonatal motoneurons from degeneration after axo-in the lateral part of the facial nucleus.
tomy (Dubois-Dauphin et al., 1994; Farlie et al., 1995)
and our demonstration of specific expression of this
Bcl-2 Is not a Permissive Factor for the protein in the adult facial motoneurons suggest that
Survival Effect of BDNF and CNTF Bcl-2 may be an essential component of the pathway
on Axotomized Motoneurons used by adult facial motoneurons to resist axotomy-
Motoneuron degeneration after axotomy in newborn an- induced degeneration. Therefore, one might expect that
imals is thought to result from the interruption of the the absence of the Bcl-2 protein would render these
supply of neurotrophic molecules from the periphery neurons more vulnerable to axonal injury. However, an
and insufficient compensation by local synthesis at the equally small percentage of adult motoneurons degen-
site of lesion (Oppenheim, 1991). In these animals, ad- erate in response to lesion of the facial nerve in both
ministration of a great variety of neurotrophic factors at bcl-22/2 and wild-type animals, implying that Bcl-2-inde-
the lesion site protects motoneurons from degeneration pendent survival mechanisms protect adult motoneu-
(Sendtner et al., 1990, 1992a; Yan et al., 1992; Hughes rons from axotomy-induced cell death. Other members
et al., 1993; Koliatsos et al., 1993; Thoenen et al., 1993). of the Bcl-2 family, like bcl-x or bax, might play a major
The absence of motoneuron degeneration after axotomy role in the survival of adult neurons or in the sensitivity
of the facial (Dubois-Dauphin et al.,1994) orsciatic nerve of neonatal neurons to axotomy. Recently, it was shown
(Farlie et al., 1995) in transgenic mice overexpressing that bcl-x is widely expressed during development of
Bcl-2 was taken to indicate that Bcl-2 is an important the nervous system, and that its expression is even
intracellular mediator of the protective action of neuro- higher in the adult CNS (Frankowski et al., 1995; Gonza´-
trophic factors. This interpretation received additional les-Garcı´a et al., 1995). In addition, significant levels
support from observations made in other neuronal sys- of Bax protein have been detected in several neuronal
tems. Microinjection of a bcl-2 cDNA expression vector populations including the CNS (Krajewski et al., 1994).
Moreover, Bax protein and mRNA levels were upregu-protected primary cultures of neurons from degenera-
lated in neurons that are destined to degenerate follow-tion resulting from withdrawal of neurotrophins (Garcia
ing various insults in the brain (Krajewski et al., 1995;et al., 1992; Mah et al., 1993; Allsopp et al., 1993) but
Gillardon et al., 1995; Hara et al., 1996).not of CNTF (Allsopp et al., 1993). Conversely, BDNF-
dependent neurons of the trigeminal mesencephalic nu-
Absence of Bcl-2 Protein Results in Loss ofcleus (TMN) were killed by antisense bcl-2 RNA in the
Sensory and Sympathetic Neurons Postnatallypresence of BDNF, but not of CNTF (Allsopp et al., 1995).
The degeneration of embryonic sensory and sympa-However, as we demonstrated here, in bcl-22/2 mice,
thetic neurons can be delayed by injection of a bcl-2local application of purified BDNF or CNTF could still
cDNA expression vector (Garcia et al., 1992; Allsopp etprevent the lesion-induced degeneration of facial moto-
al., 1993, 1995). Moreover, neuron-specific overexpres-neurons with similar efficiency as in wild-type animals.
sion of Bcl-2 in transgenic mice does not only result inThus,Bcl-2 is not an essential link in the survival cascade
an increased number of motoneurons (Martinou et al.,activated by both BDNF and CNTF to protect motoneu-
1994), but also in a significant increase of sensory neu-rons from axotomy-induced degeneration. The discrep-
rons (Farlie et al., 1995). Furthermore, the regulationancy of the effects of BDNF and CNTF between chick
of NOCD of sensory and sympathetic neurons, unlikeand mouse could reflect species differences. Indeed,
motoneurons, is determined by specific members of theessential species differences have been reported re-
NGF family (for reviews, see Snider, 1994; Davies, 1994;garding the involvement of ras p21 protein in the survival
Lewin and Barde, 1996). These observations have beenpathways activated by neurotrophins. The survival of
taken to indicate that Bcl-2 mediates the survival effectsNGF-dependent chick sympathetic neurons is neither
of neurotrophins. However, inactivation of bcl-2 did notmimicked by oncogenic p21Ras (val12), nor blocked by
result in augmented degeneration of sensory or sympa-Fab fragments of anti-p21Ras antibodies (Borasio et al.,
thetic neurons during NOCD. Although no information1993). However, active p21Ras rescues NGF-dependent
is yet available regarding the precise period of NOCDrat sympathetic neurons (Nobes et al., 1996) and Fab
in mice, studies in the rat have shown that for DRGfragments of neutralizing antibodies to p21Ras prevent
sensory neurons this period is essentially completed
the survival of rat sympathetic neurons in the presence
just after birth (Coggeshall et al., 1994). Whilst there was
of NGF (Nobes and Tolkovsky, 1995).
no substantial reduction of DRG neurons in bcl-22/2 mice
at P3, a significant reduction was found afterP9, indicat-
Effect of Axotomy in Adult bcl-22/2 Animals ing that Bcl-2 is not required for the formation of neu-
Motoneurons are highly vulnerable to injury immediately ronal progenitor cells and it is not involved in the regula-
tion of NOCD. Elimination of the bcl-2 gene affected theafter birth (Sendtner et al., 1990; Snider et al., 1992; Li
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population of large sensory neurons most severely, in Instead, neuronal degeneration actually precedes the
onset of renal impairment. Degeneration of both moto-which Bcl-2 was highly expressed as revealed by the
expression of b-galactosidase in heterozygous animals neurons and sympathetic neurons is over by P9-P10
when kidney function is still normal as reflected by se-(Figure 6) and immunohistochemical localization of
Bcl-2 in wild-type mice (data not shown). The population rum creatinine and blood urea nitrogen levels that do
not differ between bcl-22/2 and wild-type animals. Ourof small sensory neurons was also affected in bcl-22/2
mice during postnatal development, although to a lesser findings are in agreement with the observations of Veis
et al. (1993) who have shown that blood urea nitrogenextent than large DRG neurons. Whilst we could not
detect b-galactosidase activity in small DRG neurons in levels inbcl-22/2 mice start todeviate from control values
after P15. Second, it is well documented that the renalheterozygous animals, immunohistochemical analysis
in wild-type animals revealed the presence of Bcl-2-like pathological changes in bcl-22/2 animals areprogressive
with age (Veis et al., 1993; Nakayama et al., 1994; T. M.immunoreactivity in small neurons also (data not shown),
as previously reported by Merry et al. (1994). M. and J. D. C., unpublished data). Cysts begin to form
after the second postnatal week and increase in numberIn SCG neurons, the precise period of NOCD that has
been determined in rats but not in mice occurs between and volume during the lifetime of these animals. These
morphological changes are accompanied by deteriora-P3 and P7 (Wright et al., 1983). Although no significant
reduction in the number of sympathetic neurons in bcl- tion of renal function. Thus, if the neuronal deficits were
causally related to renal impairment, one might expect22/2 mice was observed at P3 a substantial loss of neu-
rons became apparent on postnatal day 10 (Table 5). It a progressive degeneration of neurons correlated tem-
porally with deteriorating renal function. This is clearlyseems that, as for motoneurons and sensory neurons,
degeneration of sympathetic neurons occurs predomi- not the case. Moreover, the observation that specific
subpopulations of neurons degenerate does not favornantly immediately after the period of NOCD, although
the period of NOCD in the murine sympathetic system a nonspecific neuronal toxicity resulting from impair-
ment of renal function. Third, a recent study in whichis not as clearly determined as it is for the facial nucleus.
Nevertheless, our in vivo observations suggest a crucial sympathetic neurons from bcl-22/2 mice were examined
in vitro further refutes the possibility that the renal im-role for Bcl-2 in mediating the survival of sympathetic
neurons during the early postnatal period. pairment may be responsible for the neuronal degenera-
tion observed in these mice. In the study of GreenlundAs shown recently, sympathetic neurons from new-
born bcl-22/2 mice, following maintenance in culture for et al. (1995), SCGs were removed from bcl-22/2 mice
and wild-type littermates at P1 or P2, individually disso-7 days in the presence of NGF, die more rapidly after
NGF deprivation than neurons from wild type littermates ciated, and then maintained in culture for 1 week in the
presence of NGF. Although there was no difference in(Greenlund et al., 1995). Importantly, this study also re-
ported that a statistically significant proportion of sym- the number of neurons recovered from either genotype
at the time of dissociation, after 1 week the neuronalpathetic neurons from bcl-22/2 mice degenerate even in
the presence of supramaximal concentrations (50 ng/ cultures from bcl-22/2 mice contained significantly fewer
neurons than cultures from wild-type littermates. Thus,aml) of NGF after 1 week in culture. Unfortunately, since
no detailed quantitative data was provided, it is difficult substantial proportion of neonatal sympathetic neurons
lacking Bcl-2 degenerate when brought in culture, withto directly compare these in vitro observations with our
in vivo findings of a substantial loss of more than 40% a similar timecourse as observed in our in vivo experi-
ments, even when removed from any potentially harmfulof sympathetic neurons by P10 in bcl-22/2 mice. Never-
theless, it seems to be clear that in bcl-22/2 mice, there internal milieu resulting from renal impairment or other
systemic abnormalities.is a loss of sympathetic neurons in the early postnatal
period that cannot be prevented by supramaximal con- In addition to renal dysfunction, abnormalities like
lymphoid hypoplasia or the smaller body size of bcl-22/2centrations of NGF and accordingly, goes far beyond
the extent of neuronal loss in NOCD that is determined mice might be considered to be partially responsible for
the neuronal degeneration. In addition to the findingsby the limited quantitites of NGF in the target area of
sympathetic neurons (Barde, 1989). of the in vitro studies of Greenlund et al. (1995) described
above, other lines of evidence suggest that such interac-
tions are very unlikely to be the primary cause for the
Neuronal Degeneration in bcl-22/2 Mice Is a Direct neuronal degeneration in bcl-22/2 mice. We found no
Consequence of the Absence of Bcl-2 correlation between the body mass of individual mutant
A striking abnormality in bcl-22/2 mice is the progressive animals and the number of surviving sensory, sympa-
development of polycystic renal malformation, accom- thetic, or motoneurons at any age examined. Moreover,
panied by corresponding gradual development renal im- comparison of mutant and wild- type animals at P9-P10,
pairment (Veis et al., 1993; Nakayama et al., 1994; when the body size of some mutant mice was still similar
T. M. M. and J. D. C., unpublished data). However, it is to that of their wild-type littermates, showed that there
unlikely that the impairment of renal function is causally was no correlation between the extent of neuronal de-
related to the neuronal degeneration observed in these generation and body mass. Furthermore, at the time-
mice, for the following reasons. First, the neuronal de- point when the neuronal degeneration in both the facial
generation observed in bcl-22/2 mice is not related tem- nucleus and the SCG is reaching a maximum (P9-P10),
porally with either the appearance of renal cysts or the the lymphoid system of bcl-22/2 mice is still developing
onset of impaired renal function as assessed by blood normally (Veis et al., 1993; Nakayama et al., 1994). Taking
all the above observations together, it is highly unlikelyurea nitrogen levels and serum creatinine concentration.
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Identification of Homologous Recombinant Cell Clonesthat neuronal degeneration occurs secondary to sys-
and Production of Mutant Micetemic dysfunctions.
Genomic DNA from individual double-drug resistant ES clones was
double digested with the restriction enzymes EcoRI and KpnI and
subjected to Southern blot analysis. The external screening probe
Conclusion A (Figure 1A) discriminated a 6.3 kb EcoRI x KpnI DNA fragment of
Elimination of thebcl-2 gene by homologous recombina- the wild-type bcl-2 allele, from a 9.3 kb DNA fragment, specific for
the recombinant allele (Figure 1B). Recombinant clones were furthertion has demonstrated that Bcl-2 is not necessary either
analyzed in Southern blots, using 39 external, as well as internal,for the generation of progenitor cells or for the regulation
probes. Of the 47 clones, three were found to carry the desiredof NOCD in at least three distinct neuronal populations
allele.
of the central and peripheral nervous system. However, Homologous recombinant ES cells were injected into 3.5 day-
Bcl-2 has an essential maintenance function for moto- old C57BL/6 blastocysts, which were subsequently implanted into
neurons of the facial nucleus, sensory neurons of DRGs pseudopregnant recipients. The resulting male chimeras were
mated to C57BL/6 females, and germline transmission of the mutantand sympathetic neurons of SCGs during the early post-
allele was identified by Southern blot analysis of tail DNA from F1natal development immediately following the period of
offspring. Heterozygous mice showed a normal phenotype and wereNOCD. Moreover, Bcl-2 is not necessary to mediate the
fertile. Heterozygotes were intercrossed to generate mice homozy-
neuroprotective effect of both BDNF and CNTF after gous for the disrupted bcl-2 gene. The body mass of these mice
axotomy of the facial nerve in newborn animals, and its was compared with wild-type littermates at three different ages.
absence does not render motoneurons more vulnerable The mean body weights did not differ at P3 (mean 6 SD: 1.81 6
0.33 g, n 5 8, versus 1.99 6 0.39 g, n 5 13 in wild-type mice, p >to injury in adulthood.
0.05). At P9 the mean weight of bcl-22/2 mice was significantly less
than wild-type littermates (mean 6 SD: 4.92 6 0.60 g, n 5 15, versus
6.24 6 1.09 g, n 5 12 in wild-type mice, p < 0.005). At later agesExperimental Procedures
the weight of bcl-22/2 mice became progressively smaller than wild-
type littermates (at P44, mean 6 SD : 16.43 6 6.29 g, n 5 6, versusConstruction of Targeting Replacement Vector
28.56 6 6.34 g,n 5 10 in wild-type mice, p < 0.005). As demonstratedScreening of a lFIX II genomic library from mouse strain 129/SV DNA
previously, the onset of mortality in bcl-22/2 mice showed a wide(Stratagene) with a 650 bp mouse bcl-2 cDNA led to the isolation of
range (Veis et al., 1993). In our animals the onset of mortality rangedthree overlapping genomic clones, that were characterized in detail
from 2–24weeks, with a clustering at 7–8 weeks. Some of the mutantby standard molecular biology techniques. One of these clones
animals lived substantially longer, with the oldest currently 1 yr old.(B6), which contained the first two exons of the gene, was used
to construct the targeting vector. Initially, a 9.1 kb DNA fragment,
Southern Blot Analysiscontaining the two exons as well as sufficient flanking sequences to
Genomic DNA restriction fragments were separated by electropho-achieve a good targeting efficiency, was subcloned in two separate
resis, and transferred onto Hybond nylon membrane (Amershampieces (EcoRI-KpnI, 6.3 kb and KpnI-EcoRI, 2.8 kb) into pBS II KS.
Corporation) as described by Sambrook et al. (1989). DNA blot hy-The resultant plasmids were the basis for the generation of the
bridization analysis was performed by conventional procedurestargeting vector, which was based upon the pGNA plasmid (Le
(Southern, 1975) with 32P-labeled probes (random priming kit, Boeh-Mouellic et al., 1992) provided by Dr. P. Bruˆlet. To remove most
ringer Mannheim).of the protein-encoding part of the bcl-2 gene, we employed the
restriction enzyme KpnI, which cuts at the begining of the second
Western Blot Analysisexon (28 bp upstream of the AUG translation initiation codon) and
Hippocampi from adult mice of all three genotypes were homoge-FspI, which cuts 52 bp downstream of the GT donor splice site of
nized in 1% SDS, 10 mM Tris buffer (pH 7.4), at a ratio of 1 mlthe second intron (Figure 1). By two successive subcloning steps,
of buffer for 1 g of tissue. Protein concentration was determinedwe generated the targeting replacement vector containing 7.5 kilo-
according to the method of Bradford (1976), with reference to abases of homologous bcl-2 genomic DNA, in which almost all of
bovine serum albumin standard. Equal amounts of protein lysatesthe protein-encoding part of the bcl-2 gene (the KpnI-FspI DNA
were analyzed by SDS-polyacrylamide gel electrophoresis ac-fragment) was removed and replaced by the lacZ. To achieve an
cording to the technique of Laemmli (1970). The proteins were trans-enrichment for the homologous recombinbation events, we used a
ferred to Immobilon-P membranes (Millipore), and blotted with amodified version (Tzimagiorgis et al., 1996) of the positive-negative
purified rabbit polyclonal antiserum (DHA7) raised against peptidesselection procedure (Mansour et al., 1988). This modification al-
31–54 of the mouse Bcl-2 protein (provided by Dr G. Evan, Imperiallowed us to introduce by a single ligation step, the negative selecion
Cancer Research Fund, London). Detection was performed aftercassette (the HSV thymidine kinase gene under the promoter of the
incubation with a peroxidase-labeled secondary antibody, whichphosphoglycerate kinase gene) at the ends of the targeting vector,
was revealed by chemiluminesent detection with the ECL kit fromafter its linearization with SpeI.
Amersham, according to the instructions of the manufacturer.
Facial Nerve Lesion and Examination of MotoneuronsElectroporation and Selection of ES Cells
The D3 ES cells (Doetschman et al., 1985) were maintained continu- Transection of the facial nerve was performed as previously de-
scribed (Sendtner et al., 1990, 1992a) both in newborn (P2) and adultously on a feeder layer of primary embryonic fibroblasts in Dulbec-
co’s modified Eagle’s medium (DMEM) containing 15% heat-inacti- (P28) mice. Briefly, newborn mice were anesthesized by hypother-
mia and the right facial nerve cut z1 mm distal to the stylomastoidvated fetal calf serum (FCS) and 60% Buffalo rat liver cell
conditioned medium in a 378C, 10% CO2-humidified incubator. ES foramen. Gel foam (Spongostan) was cut into small pieces (1 mm
long) and soaked in PBS buffer (5 ml) containing 5 mg recombinantcells (106) in 800 ml of medium 1 NaCl containing 6 mg of linearized
targeting vector were electroporated at 230 V with a 500 mF capaci- mouse BDNF(Regeneron) or 2.5mg recombinant human CNTF (Scia-
tin, a gift of Len Schleiffer, Regeneron) and placed at the lesion site.tance in a 0.4 cm wide cuvette (Bio-Rad Gene Pulser). After 5 min,
the cells were equally distributed on 4 plates. After 48 hr, G418 was Control animals were treated with gel foam soaked in PBS buffer
(5 ml) containing 5 mg cytochrome C (Sigma). After surgery, theadded to two of the plates at 380 mg/ml 1 2 mm Gancyclovir, both
for 11 days. As comparison, the other two plates were selected over wound was sutured with silk (Ethicon 3–0) and the animals returned
to their mother. Lesion of the right facial nerve was detected in thewith G418 alone. The double selection protocol resulted in a 3- to
6-fold enrichment over G418 alone. After selection, 47 G418r and animals by lack of movement of the right whisker and the right
corner of the mouth, postoperatively. On postnatal day 9, animalsGancr double-drug resistant colonies were picked for expansion,
freezing, and isolation of high molecular weight genomic DNA. were terminally anesthesized with ether and transcardially perfused
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with 4% paraformaldehyde. The brainstem was dissected, postfixed against Substance P or Neurofilament-H (Affiniti, 1:2000), or incu-
bated with biotin-labeled lectin Bandeiraea simplicifolia (BS-I)overnight, rinsed in water, dehydrated with increasing concentra-
tions of ethanol (70%–100%) and embedded in paraffin. Serial 7 (Sigma, 10 mg/ml). Subsequently, sections were incubated with
Fluorescein-conjugated swine anti-rabbit IgG (DAKO, 1:50) ormm sections were made throughout rostral-caudal extent of the
brainstem. After Nissl staining the motoneurons of both facial nuclei Texas-Red-conjugated streptavidin (Amersham, 1:40), and ob-
served by fluoresence and light microscopy.were clearly detectable. Counts of the number of motoneurons were
made in every fifth section. In each case, only neurons which con-
tained a clearly identifiable nucleolus were counted.
Histochemistry
In P28 animals, transection of the facial nerve was performed
The widespread distribution of Bcl-2 immunoreactive microglia
under ether anesthesia otherwise as described above. The animals
throughout the region of the facial nucleus during the early postnatal
were perfused two weeks later, and their brainstems were pro-
period made it difficult to clearly discriminate Bcl-2 expressing mo-
cessed as above.
toneurons in immunohistochemically stained tissue at this age. Nev-
ertheless, replacement of the bcl-2 gene by lacZ allowed us to make
Examination of Motoneurons at the Embryonic Stage E16.5 additional histochemical analysis of the facial nuclei of young mice.
To determine the extent of neuronal loss at an early stage of the For histochemical detection of b-galactosidase activity, perfusion
cell death period, we examined the facial nucleus of embryos recov- of the animals was performed with 2% paraformaldehyde in PBS
ered at E16.5, considering the plug-date of the mother as day 0.5 (pH 7.8). After removal, brains and DRG were postfixed for 30 min
of development. The embryos were rinsed once in phosphate-buf- in the same fixative, rinsed in PBS (pH 7.8) prior to cryoprotection,
fered-saline (PBS), fixed for 24 hr in PBS containing 4% paraformal- and incubated in 30% sucrose in Tris-azide buffer overnight. Subse-
dehyde, and the head of these mice, including brain and brainstems, quently, 20 mm cryostat sections were thawed directly onto pre-
were processed as described above. cleaned, gelatinized microscope slides, and stained overnight in
X-Gal-staining buffer containing 1 mg/ml 5-bromo-4-chloro-3-in-
doxyl b-D-galactoside [X-Gal], 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 2Quantification and Size Distribution of DRG Neurons
mM MgCl2 0.01% Sodium Deoxycholate, and 0.02% NP40 in PBSL3 DRGs from adult animals were individually isolated and paraffin-
at 308C on a rocking platform. The slides were then rinsed withembedded. In the case of younger animals, a tissue block containing
PBS and counterstained lightly with 0.2% neutral red, dehydratedthe lumbar DRG was dissected and decalcified in 0.25 M EDTA in
in graduated ethanols, and cleared in histoclear before mountingPB prior to embedding. Serial 7 mm sections were made throughout
under Canada Balsam (Roth). Although the histochemical stainingthe length of the DRGs from wild-type and bcl-22/2 mice. After Nissl
method is less sensitive than immunocytochemical detection ofstaining, sensory neurons containing a clearly-visible nucleolus
b-gal, the intense granular reaction product of X-Gal histochemistrywere counted in every tenth section.
permitted simple identification of cell type in Nissl-counterstainedTo analyze the cell-size distribution of DRG neurons at P44, the
sections.soma areas of L3 DRG neurons that contained a clearly visible
nucleolus were traced by camera lucida and analyzed using a mor-
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